TARSUS PHARMACEUTICALS, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $377.0M
Liabilities Breakdown FY2024
Total Liabilities: $152.5M
Asset Breakdown
Total Assets: $377.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $94.8M | 25.2% |
| Accounts Receivable | $46.8M | 12.4% |
| Inventory | $2.6M | 0.7% |
| Property, Plant & Equipment | $2.3M | 0.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $8.3M | 2.2% |
| Other Assets | $222.2M | 58.9% |
Liabilities Breakdown
Total Liabilities: $152.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $9.4M | 6.2% |
| Long-Term Debt | $71.8M | 47.1% |
| Other Liabilities | $71.2M | 46.7% |